JPMorgan raised the firm’s price target on ArcBest (ARCB) to $90 from $81 and keeps a Neutral rating on the shares. The firm adjusted targets in the transpiration and logistics group as part of a mid-quarter update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ARCB:
- ArcBest: Improving Fundamentals and Earnings Leverage Support Upside and Buy Rating
- ArcBest price target raised to $107 from $105 at Citi
- ArcBest price target lowered to $102 from $105 at BofA
- ArcBest Announces Preliminary Q1 2026 Operating Metrics
- ArcBest price target raised to $125 from $110 at Jefferies